Date: 19 Apr 2011
Is Injection Serosorting Occurring among HIV-Positive Injection Drug Users? Comparison by Injection Partner’s HIV Status
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Research needs to build evidence for the roles that HIV status of injection partners may or may not play in injection risk behaviors of injection drug users (IDUs). Using baseline data collected from a randomized controlled study (INSPIRE) conducted in four cities (Baltimore, Miami, New York, and San Francisco) from 2001 to 2005, we categorized 759 primarily heterosexual HIV-positive IDUs into four groups based on HIV serostatus of drug injection partners. Thirty-two percent of the sample injected exclusively with HIV-positive partners in the past 3 months and more than 60% had risky injection behavior with these partners. Eight percent injected exclusively with HIV-negative partners and 49% injected with any unknown status partners. The remaining 11% reported having both HIV-positive and -negative injection partners, but no partners of unknown HIV status. Riskier injection behavior was found among the group with mixed status partners. The risk among the group with any unknown status partners appeared to be driven by the greater number of injection partners. No major group differences were observed in socio-demographic and psychosocial factors. Our analysis suggests that serosorting appeared to be occurring among some, but not an overwhelming majority of HIV-positive IDUs, and knowledge of HIV status of all injection partners per se did not appear to be as important as knowledge of sexual partner’s HIV status in its association with risk behavior.
The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention
This study was supported by the Centers for Disease Control and Prevention (CDC) and the Health Resources and Services Administration (HRSA). The funding was a cooperative agreement, and thus CDC and HRSA provided significant input in study design, analysis, and interpretation of data.
Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2008. Vol. 20. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention; 2010.
Hoff CC, Stall R, Paul J, et al. Differences in sexual behavior among HIV discordant and concordant gay men in primary relationships. J Acquir Immune Defic Syndr. 1997; 14: 72–78.CrossRef
Hong DS, Rise BG, Rotheram-Borus MJ, Wong FL, Gore-Felton C, the NIHM Healthy Living Trial Group. Perceived partner serostatus, attribution of responsibility for prevention of HIV transmission, and sexual risk behavior with “main” partner among adults living with HIV. AIDS Educ Prev. 2006; 18: 150–162.PubMedCrossRef
Thiede H, Hagan H, Campbell JV, et al. Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities. Drug Alcohol Depend. 2007; 91S: S39–S47.CrossRef
Valente TW, Vlahov D. Selective risk taking among needle exchange participants: implications for supplemental interventions. Am J Public Health. 2010; 91: 406–411.
Purcell DW, Latka MH, Metsch LR, et al. Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users. J Acquir Immune Defic Syndr. 2007; 46(Suppl 2): S35–S47.PubMed
Metsch LR, Pereyra M, Purcell DW, et al. Correlates of lending needles/syringes among HIV-positive injection drug users. J Acquir Immune Defic Syndr. 2007; 46(Suppl 2): S72–S79.PubMed
Ajzen I, Fishbein M. Understanding attitudes and predicting social behavior. Englewood Cliffs, NJ: Prentice Hall; 1980.
Latka MH, Mizuno Y, Wu Y, et al. Are feelings of responsibility to limit the sexual transmission of HIV associated with safer sex among HIV-positive injection drug users? J Acquir Immune Defic Syndr. 2007; 46(Suppl2): S88–S95.PubMed
Rogers ES, Chamberlin J, Ellison ML, Crean T. A consumer-constructed scale to measure empowerment among users of mental health services. Psychiatr Serv. 1997; 48: 1042–1047.PubMed
Derogatis LR, Spencer PM. The Brief Symptom Inventory (BSI): administration, scoring, and procedure manual—1. Baltimore, MD: John Wiley; 1982.
- Is Injection Serosorting Occurring among HIV-Positive Injection Drug Users? Comparison by Injection Partner’s HIV Status
Journal of Urban Health
Volume 88, Issue 6 , pp 1031-1043
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- HIV-positive IDUs
- Injection partner’s HIV status
- Injection serosorting
- Author Affiliations
- 1. Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
- 2. 1600 Clifton Road, NE Mail Stop E37, Atlanta, GA, 30333, USA
- 3. Department of Epidemiology and Public Health, Leonard M. Miller School of Medicine, University of Miami, 1120 NW 14th Street, R-669, Miami, FL, 33136, USA
- 4. Health Equity Institute, San Francisco State University, 1600 Holloway Avenue, SP406, San Francisco, CA, 94132, USA
- 5. Department of Health, Behavior and Society, Bloomberg School of Public Health, Johns Hopkins University, 624 North Broadway Avenue, Room 286, Baltimore, MD, 21205, USA
- 6. Aurum Institute for Health Research, Postnet Suite 300, Private Bag X30500, Houghton, 2041, Johannesburg, South Africa